Thank you!
Look for a text message from us to confirm your participation
Something went wrong!
We were unable to process your request at this time.
Look for a text message from us to confirm your participation
We were unable to process your request at this time.
Learn about ORLADEYO® and make an informed decision using the videos, brochures, and discussion guides below.
Click or tap the thumbnail to play the video
Click or tap the thumbnail to play the video
Click or tap the thumbnail to play the video
Click or tap the thumbnail to play the video
Click or tap the thumbnail to play the video
Click or tap the thumbnail to play the video
Click or tap the thumbnail to play the video
Click or tap the thumbnail to play the video
Click or tap the thumbnail to play the video
To learn more, click here and sign up for ORLADEYO educational classes
Click or tap the thumbnail to play the video
To learn more, click here and sign up for ORLADEYO educational classes
Click or tap the thumbnail to play the video
To learn more, click here and sign up for ORLADEYO educational classes
Click or tap the thumbnail to play the video
To learn more, click here and sign up for ORLADEYO educational classes
Click or tap the thumbnail to play the video
To learn more, click here and sign up for ORLADEYO educational classes
Use this brochure to learn more about ORLADEYO, including how it’s given, how it works, and how it may help to prevent HAE attacks.
Download the discussion guide that best describes where you are in your journey and use it to talk to your healthcare provider about ORLADEYO and if it could be right for you.
Not yet taking a preventative therapy
Download guideCurrently taking a preventative therapy
Download guideLearn more about the ORLADEYO mentor program, including the steps to connect with an ORLADEYO mentor.
Connect with us on Facebook and Instagram for the latest information, tips, and guidance on ORLADEYO.
Look for a text message from us to confirm your participation
We were unable to process your request at this time.
Receive the latest updates on ORLADEYO and HAE.
ORLADEYO (or-luh-DAY-oh) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in adults and
children 12 years of age and older. It is not known if ORLADEYO is safe and effective in children under 12 years of age.
It is not known if ORLADEYO is safe and effective to treat an acute HAE attack, therefore ORLADEYO should not be used to treat an acute HAE attack.
Do not take more than one capsule of ORLADEYO per day because extra doses can cause heart rhythm problems.
Before taking ORLADEYO, tell your healthcare provider about all of your medical conditions, including if you
Tell your healthcare provider about all of the medicines you take, including other medicines for HAE, prescription and over-the-counter medicines, vitamins, and herbal supplements.
Taking ORLADEYO with certain other medicines may affect the way other medicines work and other medicines may affect how ORLADEYO works.
Know the medicines you take and keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
What are the possible side effects of ORLADEYO?
Taking more than one capsule of ORLADEYO per day may cause serious side effects, including heart rhythm problems. A heart rhythm problem called QT prolongation can happen in people who take more than one capsule of ORLADEYO per day. This condition can cause an abnormal heartbeat. Do not take more than one capsule of ORLADEYO per day.
The most common side effects of ORLADEYO include abdominal pain, vomiting, diarrhea, back pain, and heartburn. These are not all of the possible side effects of ORLADEYO. For more information, ask your healthcare provider or pharmacist.
Talk to your healthcare provider for medical advice about side effects.
You are encouraged to report side effects of prescription drugs to BioCryst Pharmaceuticals, Inc at 1-833-633-2279 or to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
For more information, please see the full Prescribing Information including the Patient Information.